Username Password
S&P 500: 1,348.81 Change: +0.37%

MEDCATH CP (MDTH)

Overview
Price 7.33
Price Change Today -$0.10 (-1.35%)
P&P rating Rating: 5
Zacks Rank N/A - N/A
Open Price $7.43
Previous Close $7.43
Daily Range $7.32 - $7.44
52-Week Range $6.70 - $14.96
Volume 18,000
chart
Medcath Corporation focuses on the diagnosis and treatment of cardiovascular disease. They design, develop, own and operate hospitals in partnership with cardiologists and cardiovascular surgeons that they believe have established reputations for clinical excellence. While each of their hospitals is licensed as a general acute care hospital, which provides comprehensive medical care for patients needing a wide range of healthcare services, they focus on serving the unique needs of patients suffering from cardiovascular disease.
Other Resources for MDTH
zacks.com
Commentary
Zacks Blog: Zacks.com featured expert Kevin Matras highlights: The Laclede Group, Inc., Mattel, Inc., MedCath Corp., Oxford Industries, Inc. and Tyler Technologies, Inc.
September 6, 2011
Zacks Blog: MedCath Selling Arizona Facility
August 31, 2011
Zacks Blog: MedCath Profits in 3Q
August 15, 2011
Zacks Blog: MedCath Misses, Turns to Profit
February 11, 2011
Medcath Corporation focuses on the diagnosis and treatment of cardiovascular disease. They design, develop, own and operate hospitals in partnership with cardiologists and cardiovascular surgeons that they believe have established reputations for clinical excellence. While each of their hospitals is licensed as a general acute care hospital, which provides comprehensive medical care for patients needing a wide range of healthcare services, they focus on serving the unique needs of patients suffering from cardiovascular disease.
 
Brokerage Analyst Recommendations
1 Brokerage Firms Covering MDTH
 
 
Strong Buy
0
Buy
0
Hold
1
Sell
0
Strong Sell
0
Average Broker Recommendation (ABR): 3
 
MDTH Ratings:BUY  SELL  HOLD
MDTH Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

6 Buy
0 Sell
 
Top Buy Analysis
No Buy Analysis. Be the First.

Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
Zacks_Analysts
0.00 08/31/11 MedCath Selling Arizona Facility - Analyst Blog 0
Zacks_Analysts
0.00 08/15/11 MedCath Profits in 3Q - Analyst Blog 0
Zacks_Analysts
0.00 02/11/11 MedCath Misses, Turns to Profit - Analyst Blog 0
Commentary
BUY: MEDCATH CORPORATION (MDTH) Rating: 5
Start Price: $10.29
Points: -39.18
Created: 04/24/2010

Comments: 0 | Comment

dmb dmb
Recs:
 
BUY: MEDCATH CORPORATION (MDTH) Rating: 5
Start Price: $27.03
Points: -64.62
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: MEDCATH CORPORATION (MDTH) Rating: 5
Start Price: $25.77
Points: -63.29
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: MEDCATH CORPORATION (MDTH) Rating: 5
Start Price: $27.12
Points: -64.71
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: MEDCATH CORPORATION (MDTH) Rating: 5
Start Price: $26.99
Points: -64.58
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
BUY: MEDCATH CORPORATION (MDTH) Rating: 5
Start Price: $32.95
Points: -69.52
Created: 01/01/2008

Comments: 0 | Comment

Recs:
 
Picks
Username P&P Score Call Time Frame Start Date Start Price Today (change) Stock Gain S&P Gain Points Analysis
dmb 0.33 BUY Six Months to a Year 04/24/2010 $10.29 $7.37
(-0.67%)
-28.38% +10.81% -39.18
bludiamond1 78.13 BUY Six Months to a Year 01/01/2008 $27.03 $7.37
(-0.67%)
-72.73% -8.12% -64.62
BlackTuesday 11.56 BUY Six Months to a Year 01/01/2008 $25.77 $7.37
(-0.67%)
-71.40% -8.12% -63.29
rocks 72.30 BUY Six Months to a Year 01/01/2008 $27.12 $7.37
(-0.67%)
-72.82% -8.12% -64.71
gatsbby 10.56 BUY Six Months to a Year 01/01/2008 $26.99 $7.37
(-0.67%)
-72.69% -8.12% -64.58
blagojevic 72.30 BUY Six Months to a Year 01/01/2008 $32.95 $7.37
(-0.67%)
-77.63% -8.12% -69.52
Sponsored Links